Why the study?
About 1 in 3 patients undergoing AF ablation face a redo procedure due to recurrence, and the best technique remains unknown.
Does repeat cryoablation reduce atrial fibrillation recurrence in patients with prior cryoablation compared to those with prior radiofrequency catheter ablation?
Does repeat cryoablation reduce atrial fibrillation recurrence in patients with prior cryoablation compared to those with prior radiofrequency catheter ablation?
Repeat cryoablation for atrial fibrillation recurrence is associated with higher recurrence rates in patients who previously received cryoablation compared to those who previously received radiofrequency ablation.
Answers are grounded in this paper and cite their sources.
Higher AF recurrence after repeat cryoablation in prior cryoablation patients; hypothesis-generating and requires prospective confirmation before practice change.
BACKGROUND: Ablation of atrial fibrillation (AF), both cryoablation ablation (CBA) and radiofrequency catheter ablation (RFCA), have demonstrated to be safe and effective. About 1 in 3 patients may face a redo due to recurrence and the best technique is unknown. The aim of this study is to assess the efficacy of CBA as a repeat procedure in patients with prior CBA or RFCA. METHODS: A nation-wide CBA registry (RECABA) was analyzed and patients were compared who had previously undergone CBA (Prior-CB) or RFCA (Prior-RF). The primary endpoint was AF recurrence at 12 months after a 3-month blanking period. A survival analysis was performed, univariate and multivariate Cox models were also built. RESULTS: Seventy-four patients were included. Thirty-three (44.6%) were in the Prior-CB group and 41 (55.4%) in the Prior-RF. There were more reconnected pulmonary veins in the Prior-RF than in Prior-CB group (40.4% vs.16.5%, p = 0.0001). The 12-month Kaplan-Meier estimate of freedom from AF recurrence after the blanking period was 61.0% (95% confidence interval [CI] 41.4-75.8%) in the Prior-CB, and 89.2% (95% CI 73.6-95.9%) in the Prior-RF group (p = 0.002). Multivariate Cox regression pointed Prior-CB as the sole independent predictor of AF recurrence, with an adjusted HR of 2.67 (95% CI 1.05-6.79). CONCLUSIONS: Repeat CBA shows higher rates of AF recurrences compared to CBA after a previous RFCA despite presenting less reconnected veins at the procedure. These data suggest that patients with AF recurrence after CBA may benefit from other ablation techniques after a recurrence. RECABA is registered at clinicaltrials.gov with the Unique Identifier NCT02785991.
No takes yet. Share an insight, caveat, or question.
Álvarez-Ortega et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: